Aerovate Therapeutics (AVTE)
(Real Time Quote from BATS)
$19.73 USD
-0.82 (-3.99%)
Updated Apr 30, 2024 03:40 PM ET
4-Sell of 5 4
D Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.74 |
EPS Last Quarter | -0.74 |
Last EPS Surprise | -8.82% |
ABR | 1.00 |
Earnings ESP
|
1.35% |
---|---|
Current Year | -2.78 |
Next Year | -2.90 |
EPS (TTM) | -2.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.74 | -0.68 | -2.78 | -2.90 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | -0.73 | -0.74 | -2.84 | -2.78 |
High Estimate | -0.73 | -0.61 | -2.64 | -2.78 |
Low Estimate | -0.75 | -0.74 | -2.85 | -3.00 |
Year ago EPS | -0.67 | -0.76 | -2.87 | -2.78 |
Year over Year Growth Est. | -10.45% | 10.53% | 3.14% | -4.32% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.74 | -0.68 | -2.78 | -2.90 |
7 Days Ago | -0.74 | -0.68 | -2.78 | -2.90 |
30 Days Ago | -0.75 | -0.61 | -2.71 | -2.82 |
60 Days Ago | NA | NA | -2.74 | -2.77 |
90 Days Ago | NA | NA | -2.74 | -2.58 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.73 | -0.74 | -2.84 | -2.78 |
Zacks Consensus Estimate | -0.74 | -0.68 | -2.78 | -2.90 |
Earnings ESP | 1.35% | -9.63% | -2.28% | 4.03% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.74 | -0.71 | -0.76 | -0.67 | NA |
Estimate | -0.68 | -0.70 | -0.69 | -0.58 | NA |
Difference | -0.06 | -0.01 | -0.07 | -0.09 | -0.06 |
Surprise | -8.82% | -1.43% | -10.14% | -15.52% | -8.98% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more